Camarda Financial Advisors, LLC Astrazeneca PLC Transaction History

Camarda Financial Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$40.12 - $45.47 $6,379 - $7,229	-159 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$37.28 - $41.68 $13,234 - $14,796	-355 Reduced 69.07%	159 $7,000
Q1 2019 Apr 25, 2019	BUY	$35.49 - $43.02 $18,241 - $22,112	514 New	514 $21,000
Q4 2017 Feb 07, 2018	SELL	$32.09 - $34.78 $8,535 - $9,251	-266 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$28.96 - $34.0 $7,703 - $9,044	266	266 $9,000

1,248

477M

5.99M

5.24M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $240B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Camarda Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Camarda Financial Advisors, LLC with notifications on news.